MedPath

ZEPATIER

ZEPATIER

Discontinued
DIN Number

02451131

Drug Class

Human

Market Date

Jan 25, 2016

Company
HC

Merck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02451131
AIG Number0257730001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AP54 ELBASVIR AND GRAZOPREVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.40.24
Health Canada Classification

ACTIVE INGREDIENTS (2)

ELBASVIRActive
Strength: 50 MG
Monograph: ELBASVIR
GRAZOPREVIRActive
Strength: 100 MG
Monograph: GRAZOPREVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.